HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Late needling of flat filtering blebs with adjunctive mitomycin C: efficacy and safety for the corneal endothelium.

AbstractPURPOSE:
To assess the efficacy of needle revision using mitomycin C (MMC) for reviving failed filtering blebs during the late postoperative period and its safety for the corneal endothelium.
DESIGN:
Prospective interventional case series.
PARTICIPANTS:
We recruited 125 eyes from 98 patients with uncontrolled glaucoma. All had at least 1 failed trabeculectomy, a flat filtering bleb, and a patent internal ostium on gonioscopy. The average time between the last trabeculectomy and needle revision was 5.3±5.3 years (range, 6 months to 30 years).
INTERVENTION:
Needling revision with a subconjunctival injection of 8 μg of MMC.
MAIN OUTCOME MEASURES:
Intraocular pressure (IOP) and number of hypotensive medications at latest visit, central corneal thickness (CCT), corneal endothelial cell density (ECD), coefficient of variation of cell size (CV), and hexagonality before and after needling.
RESULTS:
We performed 186 needling procedures on 125 eyes (mean, 1.5±0.6 procedures/eye). Seventy-three eyes (58.4%) were needled once, 44 eyes (35.2%) were needled twice, 7 eyes (5.6%) were needled 3 times, and 1 eye (0.8%) was needled 4 times. We reestablished aqueous flow and obtained a raised bleb in 115 eyes (92%). After an average follow-up of 20.8±12.0 months, the mean IOP decreased from 20.1±5.2 mmHg preoperatively to 13.2±6.8 mmHg (P<0.001), and the mean number of hypotensive medications per eye decreased from 2.4±1.1 to 0.8±1.3 (P<0.001) at the latest visit. The overall success rate (IOP ≤16 mmHg) was 76% (58.4% without medication and 17.6% with hypotensive medications). Kaplan-Meier survival rates were 91.2% at the 1-month follow-up, 84.5% at 6 months, 81.0% at 1 year, 74.6% at 2 years, and 66.3% at 3 years. We studied the corneal endothelium in 42 eyes of 36 patients. There was no statistically significant difference between preoperative CCT, ECD, CV, or hexagonality and postoperative measurements at 1 week and 1, 3, 6, and 12 months.
CONCLUSIONS:
Needling revision with adjunctive MMC is effective for reviving flat filtering blebs and controlling IOP, even several years after the original trabeculectomy, and seems to be safe for the corneal endothelium.
AuthorsHeloisa A Maestrini, Sebastião Cronemberger, Hérika Danielle S Matoso, José Roberto C Reis, Rafael V Mérula, Alberto Diniz Filho, Alberto Filho Diniz, Emília Sakurai, Graziele A Ferreira
JournalOphthalmology (Ophthalmology) Vol. 118 Issue 4 Pg. 755-62 (Apr 2011) ISSN: 1549-4713 [Electronic] United States
PMID21055818 (Publication Type: Journal Article)
CopyrightCopyright © 2011 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.
Chemical References
  • Alkylating Agents
  • Mitomycin
Topics
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Alkylating Agents (administration & dosage)
  • Aqueous Humor (metabolism)
  • Cell Count
  • Child
  • Child, Preschool
  • Combined Modality Therapy
  • Conjunctiva (drug effects, surgery)
  • Endothelium, Corneal (physiopathology)
  • Female
  • Filtering Surgery (instrumentation, methods)
  • Glaucoma (drug therapy, metabolism, surgery, therapy)
  • Humans
  • Intraocular Pressure
  • Male
  • Middle Aged
  • Mitomycin (administration & dosage)
  • Needles
  • Ostomy (instrumentation)
  • Postoperative Complications
  • Prospective Studies
  • Surgically-Created Structures
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: